---
title: "Brigatinib - Non-small cell lung cancer"
sidebar: mydoc_sidebar
permalink: db12267-mesh-d002289-1.html
toc: false 
---


Path ID: `DB12267_MESH_D002289_1`
{% include image.html url="images/db12267-mesh-d002289-1.png" file="db12267-mesh-d002289-1.png" alt="db12267-mesh-d002289-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C000598580 | brigatinib | Drug |
| UniProt:Q9UM73 | anaplastic lymphoma kinase (ALK) | Protein |
| UniProt:P00533 | Epidermal growth factor receptor | Protein |
| GO:0008283 | proliferation of cells | BiologicalProcess |
| CL:0001063 | tumor cell | Cell |
| MESH:D002289 | Non-small cell lung cancer | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Brigatinib | DECREASES ACTIVITY OF | Anaplastic Lymphoma Kinase (Alk) |
| Anaplastic Lymphoma Kinase (Alk) | POSITIVELY REGULATES | Proliferation Of Cells |
| Brigatinib | DECREASES ACTIVITY OF | Epidermal Growth Factor Receptor |
| Epidermal Growth Factor Receptor | POSITIVELY REGULATES | Proliferation Of Cells |
| Proliferation Of Cells | POSITIVELY CORRELATED WITH | Tumor Cell |
| Tumor Cell | POSITIVELY CORRELATED WITH | Non-Small Cell Lung Cancer |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB12267](https://go.drugbank.com/drugs/DB12267)
  - [https://www.sciencedirect.com/science/article/pii/S1319016418300902](https://www.sciencedirect.com/science/article/pii/S1319016418300902)
